Sponsor study identifier
observational
160
1 country
1
Study Start
April 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
May 2006
Actual (reported)The purpose of this study is to determine the significance of an elevated quantitative EBV PCR and to determine the relationship between a EBV PCR value and the risk of developing PTLD.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 2006
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2005
Date type not reportedThis date has not been verified as actual or estimated.
September 20, 2005
Actual (reported)September 22, 2005
Actual (reported)May 2006
Actual (reported)patients undergone pediatric heart transplant
Contact the study team to confirm eligibility.
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
Brian Kogon, MD
Emory University
160 participants (actual enrollment reported by the registry).
First Submitted
September 20, 2005
First Posted
September 22, 2005
Study Start
April 2005
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
May 2006
Actual (reported)Last Updated
March 16, 2012
Record last verified: 2007-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: